PGHH

PROCTER & GAMBLE HYGIENE & HEALTHCARE

Large Cap BSE: 500459 NSE: PGHH
₹14300.00
108.5 (0.76%)
  • Advice
  • Hold
As on 07 December, 2022 | 06:30

Procter & Gamble Hygiene & Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PROCTER & GAMBLE HYGIENE & HEALTHCARE

Start SIP

Procter & Gamble Hygiene & Healthcare Share Price

Procter & Gamble Hygiene & Healthcare Share Returns

  • Over 1 Month 1.2%
  • Over 3 Month 0.4%
  • Over 6 Month 1.48%
  • Over 1 Year -5.34%

Procter & Gamble Hygiene & Healthcare Key Statistics

P/E Ratio 90.7
PEG Ratio -5.4
Market Cap Cr 46,419
Price to Book Ratio 62.9
EPS 177.8
Dividend 1.1
Relative Strength Index 59.02
Money Flow Index 35.12
MACD Signal 17.87
Average True Range 225.09

Procter & Gamble Hygiene & Healthcare Investment Rating

  • Master Rating:
  • P&G.Hygiene & Hlth.Care has an operating revenue of Rs. 3,887.51 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 20% is great, ROE of 78% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 1% and -0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 99 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Hygiene & Healthcare Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1,0417568891,0931,058787760
Operating Expenses Qtr Cr 831709808797757712623
Operating Profit Qtr Cr 2146716529630175129
Depreciation Qtr Cr 14141313131311
Interest Qtr Cr 1173113
Tax Qtr Cr 51154875761831
Net Profit Qtr Cr 154431032122184998

Procter & Gamble Hygiene & Healthcare Technicals

EMA & SMA

Current Price
14300.
108.5 (0.76%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 14088.65
  • 50 Day
  • 14084.43
  • 100 Day
  • 14118.02
  • 200 Day
  • 14129.3
  • 20 Day
  • 14032.28
  • 50 Day
  • 14024.27
  • 100 Day
  • 14206.51
  • 200 Day
  • 14202.88

Procter & Gamble Hygiene & Healthcare Resistance and Support

PIVOT
₹14173.72
Resistance
First Resistance 14347.44
Second Resistance 14503.37
Third Resistance 14677.09
RSI 59.02
MFI 35.12
MACD Single Line 17.87
MACD 48.42
Support
First Resistance 14017.79
Second Resistance 13844.07
Third Resistance 13688.14

Procter & Gamble Hygiene & Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,536 291,614 82.47
Week 8,698 687,506 79.04
1 Month 6,649 497,124 74.77
6 Month 9,199 627,283 68.19

Procter & Gamble Hygiene & Healthcare Result Highlights

Procter & Gamble Hygiene & Healthcare Synopsis

NSE-Cosmetics/Personal Care

P&G Hygiene&Health is involved in the business activities of Manufacture of wadding of textile materials and articles of wadding such as sanitary napkins and tampoons. Company’s Total Operating Revenue is Rs. 3900.92 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 30/06/2022. Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971.
Market Cap 46,287
Sales 3,888
Shares in Float 0.94
No of funds 127
Yield 1.12
Book Value 62.76
U/D Vol ratio 0.7
LTDebt / Equity
Alpha -0.03
Beta 0.48

Procter & Gamble Hygiene & Healthcare

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 70.64%70.64%70.64%
Mutual Funds 7.56%7.47%7.15%
Insurance Companies 6.8%6.43%6.44%
Foreign Portfolio Investors 1.68%2.03%2.25%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 10.34%10.37%10.44%
Others 2.97%3.05%3.07%

Procter & Gamble Hygiene & Healthcare Management

Name Designation
Mr. Chittranjan Dua Chairman & Ind.Director
Mr. Vaidyanathan Viswanathan Lalgudi Managing Director
Mr. Pramod Agarwal Non Executive Director
Mr. Karthik Natarajan Non Executive Director
Ms. Sonali Dhawan Non Executive Director
Mr. Gagan Sawhney Non Executive Director
Mr. Ghanashyam Hegde Executive Director & Company Secretary
Mr. Anil Kumar Gupta Independent Director
Ms. Meena Ganesh Independent Director
Mr. Krishnamurthy Iyer Independent Director

Procter & Gamble Hygiene & Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Hygiene & Healthcare Corporate Action

Date Purpose Remarks
2022-11-02 Quarterly Results
2022-08-23 Audited Results & Final Dividend
2022-04-28 Quarterly Results
2022-02-01 Quarterly Results & Interim Dividend
2021-11-02 Quarterly Results
Date Purpose Remarks
2022-02-09 INTERIM Rs.95.00 per share(950%)Interim Dividend
2021-05-12 SPECIAL Rs.150.00 per share (1500%) Special Interim Dividend
2021-02-11 INTERIM Rs.85.00 per share(850%)Interim Dividend

Procter & Gamble Hygiene & Healthcare MF Shareholding

Name Amount(cr)
SBI Equity Hybrid Fund Regular Payout Inc Dist cum Cap Wdrl 56730
ICICI Prudential Bluechip Fund Growth 34823
SBI Focused Equity Fund Growth 28407
Aditya Birla Sun Life Tax Relief 96 Pyt of Inc Dis cum Cap Wdrl 13944
SBI Magnum Midcap Fund Regular Growth 8326

About Company

Procter & Gamble Hygiene and Healthcare Ltd. is a subsidiary of Procter & Gamble (P&G). They are one of India's fastest-growing FMCG companies with a portfolio of brands such as Vicks & Whisper. 

Vicks has been India's leading over-the-counter (OTC) Cough and Cold Brand since its launch in 1952. The products under this brand include Vicks Action500+, Vicks VapoRub, Vicks Cough Drops, Vicks Formula 44 Cough Syrup and Vicks Inhaler.

Whisper is another top feminine hygiene brand with a product portfolio consisting of Whisper Maxi Regular, Whisper Maxi XL Wings, Whisper Ultra with Wings and Whisper Choice.

It’s manufacturing facilities are located in Goa and Baddi in Himachal Pradesh, apart from it the company also has third-party manufacturing plants across India.

Business Verticals

P&G Hygiene and Healthcare Ltd. is engaged in manufacturing, distributing and selling personal health care products. It operates primarily in two segments: Feminine Care Business (Whisper) and Health Care Business (Vicks).

Whisper continues to be the market leader in the feminine care business. The "Comfort & Soft" segment, with the launch of Whisper Choice Aloe Vera's longer length, and the upgrade of their flagship Ultra and Choice portfolio, have transcended customer experience.

In the healthcare business, Procter & Gamble Hygiene and Healthcare Ltd. continued to win despite the challenges due to COVID-19 with the growth of Vicks' portfolio. Vicks 3-in-1 throat lozenges boosted the growth of this segment due to increased demand with world-class communication across all our sub-brands and superior go-to-market strategy. 

Milestones

1964 - On July 20, the Company was incorporated in Mumbai. 

1979 -  The premier product of the company Vicks Action 500 was launched

1985 -
In September, the Company's herbal plant in Annaram, Andhra Pradesh's Medak district, was commissioned to produce herbal and other natural ingredient products. 
Procter & Gamble Co. acquired Richardson-Vicks Inc. in October, and as a result, Richardson Hindustan Ltd. (RHL) became a Procter & Gamble Co. affiliate. Thus, the name of the Company was changed from Richardson Hindustan Ltd. to Procter & Gamble India Ltd. on April 4, 1988.

1992 - The Company introduced Whisper Extra long and Whisper Extra Large.

1993 - The Company High-Quality Whisper with Wings was introduced. 

1995 -
Vicks Vitamin 'C' is a premium line of drops introduced by the Company. 
Whisper Extra Dry, a high-performance sanitary protection product, was introduced by the Company.
The Company ventured to set up a state-of-the-art technology healthcare plant in Goa.

1996 - The Company introduced a test market for Vicks Vaporub Super Balm. 

1998 - Procter & Gamble India Ltd. has now become Procter & Gamble Hygiene and Health Care Ltd.

2000 -
The Company introduced a new brand, Tampax, to the Indian Sanitary napkin market.
Vicks cough drop was reintroduced in a new 2.5 gm blue back.
Vicks Plus medicated lozenges made their way in India.
Gary W. Cofer, country manager, Procter and Gamble, India, is the new managing director of Procter and Gamble Hygiene and Healthcare Ltd. w.e.f. September 1.
Doctoranywhere.com and Procter & Gamble Hygiene & Healthcare join hands.
Vicks Action 5000 was reintroduced in an attractive Blue international pack.

2001 -
The Company launched a Whisper Ultra Day-Night pack for the first time in Tamil Nadu, India.
They kickstarted an outdoor advertising campaign for Vicks Plus medicated lozenges.

2002 - P&G Hygiene and Health Care Ltd. announced that Mr. Gary Cofer would step down as Managing Director on April 1, 2002. Mr. Shantanu Khosla will be named Managing Director.

2003 - The Company launched a new VICKS Formula 44 cough syrup.

2004 -  'Whisper Choice' makes its entry in Tamil Nadu, Andhra Pradesh, Kerala and Karnataka with a pack of 10 pads priced at Rs 26 as a test market launch.

2019 - The Company was awarded the Packaging Innovation Awards 2019 and Best Workplaces for Innovators 2019.

2020 - The Company was awarded Top 25 Most Innovative Client Companies 2020.

Procter & Gamble Hygiene & Healthcare FAQs

What is Share Price of Procter & Gamble Hygiene & Healthcare ?

Procter & Gamble Hygiene & Healthcare share price is ₹14300 As on 07 December, 2022 | 06:16

What is the Market Cap of Procter & Gamble Hygiene & Healthcare ?

The Market Cap of Procter & Gamble Hygiene & Healthcare is ₹46418.8 Cr As on 07 December, 2022 | 06:16

What is the P/E ratio of Procter & Gamble Hygiene & Healthcare ?

The P/E ratio of Procter & Gamble Hygiene & Healthcare is 90.7 As on 07 December, 2022 | 06:16

What is the PB ratio of Procter & Gamble Hygiene & Healthcare ?

The PB ratio of Procter & Gamble Hygiene & Healthcare is 62.9 As on 07 December, 2022 | 06:16

What were the Company's most recent reported sales and net income?

Procter & Gamble Hygiene and Health Care Ltd. recorded net sales of INR 3574 as of Jun 21, 2022.

What is the future of the Company's shares?

Procter & Gamble Hygiene and Healthcare Ltd. stock is an excellent long-term (1-year) investment with an expected long-term increase in the price.

How to buy shares of Procter & Gamble Hygiene and Healthcare Ltd.?

The Company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

Q2FY23